Follow the ICON PUBLIC LIMITED COMPANY stock price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €13.1bn. The latest transaction was filed on 11 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JOHN CLIMAX. All data is openly available.
9
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,069 of 29,064 companies
39.1
score / 100
Value
46
Quality
32
FCF yld6.6%
Earn yld1.7%
EV/EBITDA20.2x
ROE0.3%
Gross mgn26%
Net mgn2.8%
Debt/EBITDA4.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
382 shares@ US$164.0736100.0% of flowCommonSEC144:0001950047-26-007844
9 of 9 declarations
About ICON PUBLIC LIMITED COMPANY
ICON Public Limited Company is a NASDAQ-listed company that specializes in research and development services for the pharmaceutical and biopharmaceutical industries.